Adnan is the youngest patient in the world to receive ABS-1230 and only the second infant to be given the experimental medication

Adnan, who has an extremely rare genetic form of epilepsy, received the medication at King’s College Hospital London – Dubai after seven previous treatment approaches failed to bring his seizures under adequate control.